SPINEMarketGroup

LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). This two-year grant (1R44AG097243-01) builds upon the work that was completed in a prior Phase I grant (1R43AG079741-01A1) and will … [Read more...] about RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures

Geneva, October 1, 2025. Swiss medtech company Spineart has secured a CHF 25 million investment to accelerate its international growth and bring new technologies to the spine surgery market. The round was supported by long-term partners Gimv and EGS Beteiligungen (EGSB), reaffirming investor confidence in the company’s trajectory.The fresh funding will enable Spineart to scale … [Read more...] about Spineart Raises CHF 25M to Boost Global Expansion and Spine Surgery Innovation

New biomaterial "EMP" adds electricity to orthopedic implants BOSTON, MA, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Scrub Capital, a venture capital firm focused on early-stage healthtech and life sciences innovation, is proud to announce its investment in Spark Spine, a pioneering medical device company developing next-generation technologies to accelerate … [Read more...] about Scrub Capital Invests in Spark Spine to Accelerate Innovation in Regenerative Medical Devices

Louisville, Colorado – October 1 – Synergy Spine Solutions, an innovative orthopaedic medical device company focused on artificial cervical disc replacement, today announced the expansion of its sales agency agreement with Johnson & Johnson MedTech Germany. This agreement builds on the success of the existing sales agency agreements with Johnson & Johnson Medtech … [Read more...] about Synergy Spine Solutions and Johnson & Johnson MedTech Extend Strategic Collaboration into Germany

BIOBank, a French leader in bone allografts, and Spineart are proud to announce a strategic partnership aimed at improving access to high-quality allogenic bone substitutes for spine surgeons in France and Switzerland. A Synergistic Approach to Spinal Fusion Under the agreement, Spineart will promote BIOBank’s portfolio, with a focus on BIOBank Synergy® – a moldable … [Read more...] about Spineart and Biobank announce Strategic Partnership for spine surgery in France and Switzerland

MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S. clinical trial evaluating VIA Disc NP™ for patients with lumbar discogenic pain associated with degenerative disc disease (DDD). “We are proud to advance the clinical evaluation of … [Read more...] about Vivex Biologics Treats First Patient in its Restore Trial Evaluating VIA Disc NP™ for Patients with Degenerative Disc Disease

FORT LAUDERDALE, Fla., Sept. 30, 2025 /PRNewswire/ -- As the spine industry today continues to double down on rigid fixation and hospital-driven procedures, orthopedic spine surgeon, professor, and KIC Ventures CEO & Founder Dr. Kingsley R. Chin stands out for having charted a different course years earlier. In his 2018 keynote at the 32nd Annual Meeting of the Korean … [Read more...] about Why MedTech Investors Must Heed: Dr. Kingsley R. Chin’s Historic Keynote in South Korea Spotlights the Next Wave of Spine Innovations

Schlieren (Zürich), Switzerland – September 30, 2025 – Kuros Biosciences (“Kuros” or the “Company”), a leader in innovative biologic technologies, today announced the full commercial launch of the MagnetOs™ MIS Delivery System. Purpose-built for Minimally Invasive Surgical (MIS) procedures, the system is designed to meet every surgeon’s need in bone graft delivery. It will … [Read more...] about Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025

Yesterday we highlighted the remarkable innovation of a bone-based adhesive that could one day replace metal implants in spinal fracture repair. Today we continue on the path of disruptive medical advances, this time focusing on degenerative spinal conditions — where new technologies may not only complement but potentially eliminate the need for conventional hardware in … [Read more...] about Will biology replace metal in healing the spine?

CARLSBAD, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the appointment of Jenifer Kamocsay as Chief Legal Officer and Secretary, effective immediately. Ms. Kamocsay will serve as legal counsel for the Company and … [Read more...] about Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary

This September 2025, Chinese media highlighted a biomedical breakthrough that could reshape orthopedic practice: the bioabsorbable adhesive Bone-02, developed in Zhejiang Province and already tested in more than 150 patients with complex fractures. Inspired by the way oysters adhere firmly under water, this “bone glue” is reported to fix bone fragments in just two to three … [Read more...] about Could Bone-02 Replace Metal Implants in Spine Fractures?